Immunity Afforded Manufacturers, Distributors and Users of Countermeasures with Respect to COVID-19 Claims
Life Sciences practice chair Dan Tranen and associate Megan Verbos discuss the HHS Secretary declaration under the PREP Act and how this may permit various medical device and drug manufacturers, distributors and users of COVID-19 countermeasures to become effectively exempt from civil liability if their activities cause harm to patients or others. Topics will include:
Specific legal process that creates immunity for specific countermeasures
Exceptions and limitations to that immunity
Examination of specific countermeasures that are trending in the news
Ways in which their use may or may not lead to civil liability exemption under the PREP Act.